Inari Medical to Present at the Canaccord Genuity 40th Annual Growth Conference

Rhea-AI Summary

Inari Medical, Inc. (NASDAQ: NARI) will participate in the Canaccord Genuity 40th Annual Virtual Growth Conference, set for August 12 at 4:30 p.m. Eastern Time. Live and archived webcasts of the presentation will be available on their website. Inari focuses on treating venous diseases, specifically venous thromboembolism, using innovative catheter-based devices. The company’s FDA-cleared ClotTriever system addresses deep vein thrombosis, while the FlowTriever system is designed for pulmonary embolism treatment.

IRVINE, Calif., July 29, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) today announced the company will be participating in the upcoming Canaccord Genuity 40th Annual Virtual Growth Conference.

Inari’s management is scheduled to present on Wednesday, August 12 at 4:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investor Relations” section of the company’s website at: https://www.inarimedical.com/.

About Inari Medical, Inc.
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.

Inari is focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.

Investor Contact:
Westwicke Partners
Caroline Corner
Phone +1-415-202-5678
caroline.corner@westwicke.com

FAQ

What date will Inari Medical present at the Canaccord Genuity conference?

Inari Medical will present on August 12 at 4:30 p.m. Eastern Time.

How can I access Inari Medical's presentation at the conference?

You can access the live and archived webcast on Inari Medical's website in the Investor Relations section.

What is the focus of Inari Medical's product development?

Inari Medical focuses on developing products for treating venous diseases, particularly venous thromboembolism.

What FDA-cleared devices does Inari Medical offer?

Inari Medical offers the ClotTriever and FlowTriever systems, both FDA-cleared for treating different types of venous clots.

What conditions do the ClotTriever and FlowTriever systems treat?

The ClotTriever treats deep vein thrombosis, while the FlowTriever is designed for pulmonary embolism.